{
  "Symbol": "SOLV",
  "AssetType": "Common Stock",
  "Name": "Solventum Corp.",
  "Description": "Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. The company is headquartered in Saint Paul, Minnesota.",
  "CIK": "1964738",
  "Exchange": "NYSE",
  "Currency": "USD",
  "Country": "USA",
  "Sector": "LIFE SCIENCES",
  "Industry": "SURGICAL & MEDICAL INSTRUMENTS & APPARATUS",
  "Address": "3M CENTER, BUILDING 275-6W, 2510 CONWAY AVENUE EAST, MAPLEWOOD, MN, UNITED STATES",
  "OfficialSite": "https://www.solventum.com",
  "FiscalYearEnd": "December",
  "LatestQuarter": "2024-12-31",
  "MarketCapitalization": "11463163000",
  "EBITDA": "1647000000",
  "PERatio": "23.17",
  "PEGRatio": "None",
  "BookValue": "17.12",
  "DividendPerShare": "None",
  "DividendYield": "None",
  "EPS": "2.76",
  "RevenuePerShareTTM": "47.66",
  "ProfitMargin": "0.058",
  "OperatingMarginTTM": "0.0954",
  "ReturnOnAssetsTTM": "0.0481",
  "ReturnOnEquityTTM": "0.0655",
  "RevenueTTM": "8254000000",
  "GrossProfitTTM": "4612000000",
  "DilutedEPSTTM": "2.76",
  "QuarterlyEarningsGrowthYOY": "-0.886",
  "QuarterlyRevenueGrowthYOY": "0.019",
  "AnalystTargetPrice": "80.89",
  "AnalystRatingStrongBuy": "0",
  "AnalystRatingBuy": "1",
  "AnalystRatingHold": "9",
  "AnalystRatingSell": "0",
  "AnalystRatingStrongSell": "1",
  "TrailingPE": "23.17",
  "ForwardPE": "11.52",
  "PriceToSalesRatioTTM": "1.389",
  "PriceToBookRatio": "3.738",
  "EVToRevenue": "2.218",
  "EVToEBITDA": "11.99",
  "Beta": "None",
  "52WeekHigh": "85.92",
  "52WeekLow": "47.16",
  "50DayMovingAverage": "73.67",
  "200DayMovingAverage": "68.21",
  "SharesOutstanding": "173003000",
  "DividendDate": "None",
  "ExDividendDate": "None",
  "Last Updated": "2025-04-23 14:46:01",
  "Price_Day_1": 64.94,
  "Price_Day_2": 63.94,
  "Price_Day_3": 66.26,
  "Price_Day_4": 65.67,
  "Price_Day_5": 65.93,
  "Price_Day_6": 67.8,
  "Price_Day_7": 66.19,
  "Income_totalRevenue_Q1": "2074000000",
  "Income_grossProfit_Q1": "1119000000",
  "Income_netIncome_Q1": "30000000",
  "Income_totalRevenue_Q2": "2082000000",
  "Income_grossProfit_Q2": "1165000000",
  "Income_netIncome_Q2": "122000000",
  "Income_totalRevenue_Q3": "2081000000",
  "Income_grossProfit_Q3": "1137000000",
  "Income_netIncome_Q3": "89000000",
  "Income_totalRevenue_Q4": "2016000000",
  "Income_grossProfit_Q4": "1173000000",
  "Income_netIncome_Q4": "237000000",
  "Balance_totalAssets_Q1": "14457000000",
  "Balance_totalLiabilities_Q1": "11498000000",
  "Balance_totalShareholderEquity_Q1": "2959000000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q1": "762000000",
  "Balance_totalAssets_Q2": "14745000000",
  "Balance_totalLiabilities_Q2": "11553000000",
  "Balance_totalShareholderEquity_Q2": "3192000000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q2": "772000000",
  "Balance_totalAssets_Q3": "14578000000",
  "Balance_totalLiabilities_Q3": "11711000000",
  "Balance_totalShareholderEquity_Q3": "2867000000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q3": "897000000",
  "Balance_totalAssets_Q4": "14711000000",
  "Balance_totalLiabilities_Q4": "10860000000",
  "Balance_totalShareholderEquity_Q4": "3851000000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q4": "996000000",
  "Debt to Equity Ratio": 3.89,
  "Is Complete": true
}